XTL BIOPHARMACEUTICALS LTD. Increase Decrease Through Exercise Of Warrants Equity
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Increase Decrease Through Exercise Of Warrants Equity of $3.98 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2025-04-30
- XTL BIOPHARMACEUTICALS LTD. increase decrease through exercise of warrants equity for the quarter ending 2021-06-30 was $55.00K.
| Period end | Increase Decrease Through Exercise Of Warrants Equity 3 month | Increase Decrease Through Exercise Of Warrants Equity 6 month | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|---|---|
| 2024-12-31 | $3.98M 20-F · filed 2025-04-30 | ||
| 2021-12-31 | $1.25M 20-F · filed 2023-03-22 | ||
| 2021-06-30 | $55.00K 6-K · filed 2021-08-24 | $512.00K 6-K · filed 2022-08-24 | |
| 2015-12-31 | $3.38M 20-F · filed 2018-03-15 |